Maintaining high levels of syngeneic bone marrow engraftment while omitting cyclophosphamide in busulfan-containing conditioning regimens.
Robbin Westerhof
G
G
Ploemacher
R E
RE
Down
J D
JD
D000818:Animals; D016026:Bone Marrow Transplantation / Q000473:pathology*; D002066:Busulfan / Q000008:administration & dosage / Q000627:therapeutic use* / Q000633:toxicity; D003520:Cyclophosphamide / Q000008:administration & dosage* / Q000627:therapeutic use / Q000633:toxicity; D006085:Graft Survival; D051379:Mice; D011828:Radiation Chimera; D019172:Transplantation Conditioning / Q000379:methods*; D014184:Transplantation, Homologous / Q000473:pathology
D003520:Cyclophosphamide; D002066:Busulfan